BBR might function through inactivating PI3K/AKT and Raf/MEK/ERK signaling pathway, inhibiting the phosphorylation of Akt and ERK proteins, and downregulating HIF-1α signaling to inhibit tumor cell growth. The gene discussed is AKT1; the disease is neoplasm.